Social Media Content Creators Driving Unofficial Trade for Unlicensed Slimming Drug

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of rapid British shipping. Sellers market the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting products of unknown origin.

Several experts stated the demand for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Removal

According to TikTok, the service has taken down problematic material and banned related keywords and query recommendations. The organization stated it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

After minutes of joining one community, a vendor shared WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Pricing

Inside these groups, posts show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service stated it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially serious medical dangers”.

Emily Robertson
Emily Robertson

Urban technology researcher and smart city strategist with 15 years of experience in sustainable development.